Durable Tumor Control with Multi-Organ Immune-Related Adverse Events Following Immune Checkpoint Inhibitor and Sequential Radiotherapy in Locally Advanced NSCLC: A Case Report

Zhai M, Liu X, Li Y, Pi G, Bi J, Han G

ImmunoTargets and Therapy 2025, 14:1411-1417

Published Date: 10 December 2025